SkinPen Precision Wins the 2021 Aesthetic Award for Best Nonsurgical Technology in the Industry

Posted By American Med Spa Association, Friday, October 15, 2021

Crown Aesthetics, a division of Crown Laboratories and a global leader in microneedling technology, is proud to announce that SkinPen Precision has again been recognized as an industry best for its superior innovation and technology. Presented by The Aesthetic Guide, the Aesthetic Awards shine a spotlight on product manufacturers and practice management companies that are shaping the future of aesthetic medicine. 

SkinPen Precision is the first FDA-cleared microneedling device on the market. In the United States, SkinPen is clinically proven to improve the appearance of wrinkles on the neck for Fitzpatrick skin types II - IV and to improve the appearance of facial acne scars in adults with all Fitzpatrick skin types aged 22 years and older. In the EU, SkinPen is also intended to treat pigmentation conditions (Dyschromia) including Melasma, Vitiligo, and Solar Lentigines. Indications for SkinPen Precision may vary based on the country.

SkinPen has passed more than 90 validated tests to set the standard in microneedling. SkinPen's handpiece is ergonomically designed based on user feedback and is ultrasonically sealed for ease of cleaning and increased patient safety. SkinPen's superior cartridge design inhibits the entrance of fluids into the device which, along with the Bio-sheath and routine cleaning, help to prevent potential cross-contamination. The patented cartridge features proprietary technology that includes 14 stainless steel needles that have been validated to stay sharp for a least 80 minutes. With patient safety top-of-mind, the single-use lockout feature eliminates the possibility of double usage and cross-contamination. This safe and versatile treatment can be performed on patients year-round.

Read more at Tyler Morning Telegraph >>